Genomic Insights into Antimicrobial Resistance in Enterobacterales, Pseudomonas, and Acinetobacter

Dear Colleagues,

Antimicrobial resistance, which compromises the effectiveness of antimicrobials and increases the risk of microbial infections, is currently a pressing global public health threat. Notably, Gram-negative bacterial species, such as Enterobacterales, Pseudomonas, and Acinetobacter, possess a high propensity for acquiring multidrug resistance, and infections with these multidrug-resistant clones lead to refractory or exacerbated disease conditions. Consequently, the mortality rate of severe infections, such as pneumonia and sepsis, tends to increase. The application of genomic approaches in antimicrobial resistance research has been notably developed in recent years. While understanding the emergence, mutation, transmission, and epidemiology have yielded significant benefits to humanity, much still remains to be done.

In this Special Issue titled ‘Genomic Insights into Antimicrobial Resistance in Enterobacterales, Pseudomonas and Acinetobacter’, our focus will be on a variety of topics related to the genomic understanding of these clinically important bacteria. Primary areas of interest encompass sequencing analysis of resistant isolates and microbiome samples from clinical and environmental settings; identification and functional characterization of resistance genes and mutations; pathogenomic analysis of resistant clones using in vitro and in vivo infection models. We encourage research that uncovers the complex genomic structures and novel resistance mechanisms, mobilomes facilitating resistance gene transfer, population genomics and epidemiology, and methodologies.

We will accept submissions of primary research reports, reviews, as well as meta-analyses. Please note that all submitted papers will be peer-reviewed.

Dr. Taishi Tsubouchi
Dr. Masato Suzuki
Prof. Dr. Yukihiro Kaneko
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antimicrobial resistance
• Pseudomonas aeruginosa
• Klebsiella pneumoniae
• Acinetobacter baumannii
• microbial genomics
• transmission mechanisms
• mobile elements